Lv61
2138 积分 2024-04-22 加入
Patients harboring uncommon EGFR exon 19 deletion-insertion mutations respond well to first-generation EGFR inhibitors and osimeritinib upon acquisition of T790M
28天前
已完结
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
1个月前
已完结
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained Individuals
2个月前
已完结
Uncommon EGFR mutations in advanced non-small cell lung cancer
3个月前
已完结
Molecular Profiling across 80,000 Patients with Lung Cancer
3个月前
已完结
Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0
4个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
4个月前
已完结
NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion
6个月前
已完结
High‐grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor
6个月前
已完结
Secretory carcinoma in the parotid gland presenting as a cystic lesion and harboring ETV6‑NTRK3 gene rearrangement
6个月前
已完结
皖公网安备34019202002308
